SAN ANTONIO: In patients with Parkinson’s disease, the development of amyloid plaque might be a two-step process — cortical deposits followed by striatal deposits — new research suggests.
“The clinical implication is that the early detection of cortical-only plaques in patients may provide a window of therapeutic opportunities for anti-amyloid therapies,” said…